Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-002650
Filing Date
2016-06-16
Accepted
2016-06-16 16:02:57
Documents
1
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4053
  Complete submission text file 0001562180-16-002650.txt   5443
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDIVATION, INC. 201 SPEAR ST., 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 161717634